Faysal brings over 26 years of experience in pharmaceutical drug development and commercialization, including 21 years in portfolio management, research and development, and business development. He specializes in generics and biosimilars, with deep expertise in product portfolio strategy, IP assessment, and R&D.

Faysal joined Adalvo in August 2023. Previously, he held various management positions at Synthon for nearly 16 years before joining Alvogen in 2015 as Executive Vice President of Portfolio, Business Development, and R&D. In 2022, he moved to Alvotech, serving as COO and Head of Portfolio and Product Management.

He holds a Master’s degree in Chemistry from Radboud University, Nijmegen, and an Executive MBA from INSEAD.

Faysal Kalmoua